8/9/2011

Long-term treatment with midodrine in addition to standard medical care increased survival and improved ascites control for cirrhotic patients in a pilot study of 40 patients reported in the Journal of Hepatology. Patients in the treatment group had increases in average arterial pressure, urinary volume and urine sodium excretion, and demonstrated a drop in plasma renin activity and plasma aldosterone concentrations.

Related Summaries